1 – 50 of 116
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Anoikis-related genes linked with patient outcome in pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
2024) In Scandinavian Journal of Surgery(
- Contribution to journal › Article
-
Mark
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Microbiome alterations in pancreatic cancer : new insights and potential clinical implications
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Acute pancreatitis–one key to early detection of pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
Model-based screening for pancreatic cancer in Sweden
(
- Contribution to journal › Article
-
Mark
Histopathological investigation of colon liver metastases–which factors affect survival after surgery?
(
- Contribution to journal › Article
- 2022
-
Mark
Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Surgical resection of pancreatic cancer with synchronous hepatic oligometastases : Real benefit or selection bias?
(
- Contribution to journal › Letter
-
Mark
Pancreatic cancer–the past, the present, and the future
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Surgical Infections and Antibiotic Stewardship : In Need for New Directions
(
- Contribution to journal › Article
-
Mark
Macropinocytosis : the Achilles’ heel of pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
IPMN of the pancreas–does histological subtyping allow for improved stratification and follow-up?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Acute pancreatitis–can evidence-based guidelines be transferred to an optimized comprehensive treatment program?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
-
Mark
Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas
(
- Contribution to journal › Article
-
Mark
Projected economic burden of pancreatic cancer in Sweden in 2030
(
- Contribution to journal › Article
- 2020
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
(
- Contribution to journal › Article
-
Mark
The Dilemma of Drains after Pancreatoduodenectomy : Still an Issue?
(
- Contribution to journal › Article
-
Mark
Re-resection for incidentally detected gallbladder cancer : Weighing in on the options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Blood-based markers for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas–what’s beyond the horizon?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
(
- Contribution to journal › Article
-
Mark
Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
(
- Contribution to journal › Article
-
Mark
Proteomic and genomic profiling of pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer
(
- Contribution to journal › Scientific review
-
Mark
Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Early postoperative fluid retention is a strong predictor for complications after pancreatoduodenectomy
(
- Contribution to journal › Article
-
Mark
Sustainability of an Enhanced Recovery Program for Pancreaticoduodenectomy with Pancreaticogastrostomy
(
- Contribution to journal › Article
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of PEDF in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
(
- Contribution to journal › Article
-
Mark
Diagnosis and management of duodenal perforations : a narrative review
(
- Contribution to journal › Scientific review
-
Mark
Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Early-onset pancreatic cancer : a population-based study using the SEER registry
(
- Contribution to journal › Article
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
(
- Contribution to journal › Scientific review
- 2018
-
Mark
High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm
(
- Contribution to journal › Article
-
Mark
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype
(
- Contribution to journal › Article
-
Mark
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Centrosomal Abnormalities in Pancreatic Cancer : Molecular Mechanisms and Clinical Implications
(
- Contribution to journal › Scientific review
-
Mark
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Intraductal Papillary Mucinous Neoplasms of the Pancreas : A Nationwide Registry-Based Study
(
- Contribution to journal › Article
-
Mark
Targeting dendritic cells in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
The prognostic role of cancer stem cell markers for long-term outcome after resection of colonic liver metastases
(
- Contribution to journal › Article
-
Mark
Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment
(
- Contribution to journal › Scientific review